Literature DB >> 19406949

Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.

Anne M Rowzee1, Dale L Ludwig, Teresa L Wood.   

Abstract

The insulin receptor (IR) isoforms and the IGF type 1 receptor (IGF-1R) share a high degree of structural homology but differ in ligand binding kinetics and functions. We developed a highly specific quantitative PCR assay to quantify and compare IR-A, IR-B, and IGF-1R expression within an RNA population. We determined receptor expression in primary murine mammary epithelial cells (MECs) during postnatal development. Both IR isoform mRNAs were 3- to 16-fold higher than IGF-1R expression at all developmental times. IR protein was also 3- to 10-fold higher than IGF-1R protein; however, significantly less IGF-1R was found in hybrid receptors at early (49%) vs. late (79%) pregnancy, indicating that the amount of hybrid receptor is developmentally regulated. Despite high IR expression, IGF ligands were more effective than insulin in stimulating the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt pathway in acutely isolated MECs from virgin glands. Although approximately 40% of IR transcripts were the IGF-II-sensitive IR-A isoform, IGF-II failed to stimulate IR phosphorylation, and an IGF-1R-specific blocking antibody completely abrogated IGF-II-mediated Akt phosphorylation in the virgin MECs. Taken together, these data suggest that the IGF-1R is more active in signaling than the IR and is the predominant mediator of IGF actions in virgin MECs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406949      PMCID: PMC2717875          DOI: 10.1210/en.2008-1473

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  41 in total

1.  Rapid induction of IGF-IR signaling in normal and tumor tissue following intravenous injection of IGF-I in mice.

Authors:  A V Lee; S T Taylor; J Greenall; J D Mills; D W Tonge; P Zhang; J George; M L Fiorotto; D L Hadsell
Journal:  Horm Metab Res       Date:  2003 Nov-Dec       Impact factor: 2.936

2.  Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.

Authors:  Giuseppe Pandini; Francesco Frasca; Rossana Mineo; Laura Sciacca; Riccardo Vigneri; Antonino Belfiore
Journal:  J Biol Chem       Date:  2002-07-22       Impact factor: 5.157

3.  Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I.

Authors:  R Gregg Richards; Diane M Klotz; Michael P Walker; Richard P Diaugustine
Journal:  Endocrinology       Date:  2004-04-01       Impact factor: 4.736

4.  Local insulin-like growth factor-II mediates prolactin-induced mammary gland development.

Authors:  Russell C Hovey; Jessica Harris; Darryl L Hadsell; Adrian V Lee; Christopher J Ormandy; Barbara K Vonderhaar
Journal:  Mol Endocrinol       Date:  2002-12-23

5.  Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1.

Authors:  Laura Sciacca; Marco Prisco; An Wu; Antonino Belfiore; Riccardo Vigneri; Renato Baserga
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

6.  Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland.

Authors:  A V Lee; P Zhang; M Ivanova; S Bonnette; S Oesterreich; J M Rosen; S Grimm; R C Hovey; B K Vonderhaar; C R Kahn; D Torres; J George; S Mohsin; D C Allred; D L Hadsell
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

7.  Developmental changes in insulin-like growth factor I receptor gene expression in the mouse mammary gland.

Authors:  Geetanjalee Modha; Anne Blanchard; Barbara Iwasiow; Xiao Juan Mao; Sandra Troup; Adewale Adeyinka; Peter Watson; Robert Shiu; Yvonne Myal
Journal:  Endocr Res       Date:  2004-02       Impact factor: 1.720

8.  Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling.

Authors:  Kimberly R Kalli; Oluwole I Falowo; Laurie K Bale; Michael A Zschunke; Patrick C Roche; Cheryl A Conover
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

9.  Bi-directional regulation of brown fat adipogenesis by the insulin receptor.

Authors:  Amelia J Entingh; Cullen M Taniguchi; C Ronald Kahn
Journal:  J Biol Chem       Date:  2003-06-13       Impact factor: 5.157

10.  The mRNA expression of insulin receptor isoforms (IR-A and IR-B) and IGFR-2 in the bovine corpus luteum during the estrous cycle, pregnancy, and induced luteolysis.

Authors:  Tanja Pascale Neuvians; Michael Walter Pfaffl; Bajram Berisha; Dieter Schams
Journal:  Endocrine       Date:  2003-11       Impact factor: 3.925

View more
  23 in total

1.  Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAs.

Authors:  Sarah F Andres; M Agostina Santoro; Amanda T Mah; J Adeola Keku; Amy E Bortvedt; R Eric Blue; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-11-13       Impact factor: 4.052

2.  IGF-II promotes stemness of neural restricted precursors.

Authors:  Amber N Ziegler; Joel S Schneider; Mei Qin; William A Tyler; John E Pintar; Diego Fraidenraich; Teresa L Wood; Steven W Levison
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

3.  Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation.

Authors:  Sarah F Andres; James G Simmons; Amanda T Mah; M Agostina Santoro; Laurianne Van Landeghem; P Kay Lund
Journal:  J Cell Sci       Date:  2013-10-14       Impact factor: 5.285

Review 4.  Does Insulin Explain the Relation between Maternal Obesity and Poor Lactation Outcomes? An Overview of the Literature.

Authors:  Laurie A Nommsen-Rivers
Journal:  Adv Nutr       Date:  2016-03-15       Impact factor: 8.701

5.  Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma.

Authors:  Clare A Flannery; Farrah L Saleh; Gina H Choe; Daryl J Selen; Pinar H Kodaman; Harvey J Kliman; Teresa L Wood; Hugh S Taylor
Journal:  J Clin Endocrinol Metab       Date:  2016-04-18       Impact factor: 5.958

6.  Decreased IGF type 1 receptor signaling in mammary epithelium during pregnancy leads to reduced proliferation, alveolar differentiation, and expression of insulin receptor substrate (IRS)-1 and IRS-2.

Authors:  Zhaoyu Sun; Sain Shushanov; Derek LeRoith; Teresa L Wood
Journal:  Endocrinology       Date:  2011-05-31       Impact factor: 4.736

7.  IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.

Authors:  Lauren M Rota; Lidia Albanito; Marcus E Shin; Corey L Goyeneche; Sain Shushanov; Emily J Gallagher; Derek LeRoith; Deborah A Lazzarino; Teresa L Wood
Journal:  Cancer Res       Date:  2014-08-04       Impact factor: 12.701

Review 8.  Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts.

Authors:  Julie A Wickenden; Christine J Watson
Journal:  Breast Cancer Res       Date:  2010-04-09       Impact factor: 6.466

Review 9.  The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.

Authors:  V Kate Gatenby; Helen Imrie; Mark Kearney
Journal:  Pflugers Arch       Date:  2013-01-22       Impact factor: 3.657

10.  Diet-induced metabolic change induces estrogen-independent allometric mammary growth.

Authors:  Grace E Berryhill; Julia M Gloviczki; Josephine F Trott; Lucila Aimo; Jana Kraft; Robert D Cardiff; Carly T Paul; Whitney K Petrie; Adam L Lock; Russell C Hovey
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.